SCHEMBL19853393

SCHEMBL19853393

CCCC(=O)N(C(=O)NCC)C(C)C

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNB2 P17787 2/20 0.35
CHRNB4 P30926 2/20 0.35
CHRNA3 P32297 2/20 0.35
CHRNA4 P43681 2/20 0.35
FAAH O00519 1/20 0.34
ALDH1A1 P00352 1/20 0.34
GAA P10253 1/20 0.34
HDAC3 O15379 2/20 0.31
HDAC1 Q13547 2/20 0.31
HDAC2 Q92769 2/20 0.31
HDAC8 Q9BY41 2/20 0.31
HDAC6 Q9UBN7 1/20 0.31
CA12 O43570 1/20 0.31
CA9 Q16790 1/20 0.31
CES2 O00748 1/20 0.31
CES1 P23141 1/20 0.31
CAPN1 P07384 1/20 0.31
CTSD P07339 1/20 0.30
SMN1; SMN2 Q16637 1/20 0.30
FFAR3 O14843 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24065709 0.76 ALDH1A1 (0.36) CHRNB2CHRNB4CHRNA3CHRNA4ALDH1A1
SCHEMBL23187897 0.74 ALDH1A1 (0.35) CHRNB2CHRNB4CHRNA3CHRNA4FAAH
SCHEMBL3276345 0.70 ALDH1A1 (0.41) CHRNB2CHRNB4CHRNA3CHRNA4FAAH
SCHEMBL966430 0.69 CHRNB2 (0.40) CHRNB2CHRNB4CHRNA3CHRNA4FAAH
SCHEMBL2035630 0.68 CES2 (0.41) ALDH1A1HDAC3HDAC1HDAC2HDAC8
SCHEMBL967637 0.67 ALDH1A1 (0.42) CHRNB2CHRNB4CHRNA3CHRNA4ALDH1A1
SCHEMBL4138857 0.66 ALDH1A1 (0.41) CHRNB2CHRNB4CHRNA4ALDH1A1GAA
SCHEMBL20998547 0.65 SMN1; SMN2 (0.35) CHRNB2CHRNA4ALDH1A1GAASMN1; SMN2
SCHEMBL17285706 0.64 EPHX2 (0.39) ALDH1A1HDAC3HDAC1HDAC2HDAC8
Hydrochloric Acid SCHEMBL27323795 0.64 ALDH1A1 (0.39) CHRNB2CHRNB4CHRNA4ALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180036308-A1 NOVEL COMPOUNDS AUTIFONY SRL (IT) 2018-02-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180036308-A1 NOVEL COMPOUNDS CYFIP1, CYFIP2, ZFX CHRNB2 403/4885CHRNB4 562/4885CHRNA3 1224/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.